An Observational Study to Assess Correlation Between Prostate Specific Antigen and Beck Anxiety Index in Prostate Cancer Patients Under Hormonal Therapy [bicalutamide, goserelin].

Trial Profile

An Observational Study to Assess Correlation Between Prostate Specific Antigen and Beck Anxiety Index in Prostate Cancer Patients Under Hormonal Therapy [bicalutamide, goserelin].

Completed
Phase of Trial: Phase IV

Latest Information Update: 27 Jan 2010

At a glance

  • Drugs Bicalutamide; Goserelin
  • Indications Prostate cancer
  • Focus Therapeutic Use
  • Acronyms CHAMPION
  • Sponsors AstraZeneca
  • Most Recent Events

    • 27 Jan 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 08 Sep 2008 Actual start date changed from Jun 2007 to May 2007 as reported by Clinicaltrials.gov.
    • 08 Sep 2008 Planned end date added (1 Apr 2009) as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top